Similar articles

• Blood pressure reductions following catheter-based renal denervation are not related to improvements in adherence to antihypertensive drugs measured by urine/plasma toxicological analysis.

  Ewen S, Meyer MR, Cremers B, Laufs U, Helfer AG, Linz D, Kindermann I, Ukena C, Burnier M, Wagenpfeil S, Maurer HH, Böhm M, Mahfoud F. Ewen S, et al. Clin Res Cardiol. 2015 Dec;104(12):1097-105. doi: 10.1007/s00392-015-0905-5. Epub 2015 Aug 26. Clin Res Cardiol. 2015. PMID: 26306594
• Adherence to Antihypertensive Treatment and the Blood Pressure-Lowering Effects of Renal Denervation in the Renal Denervation for Hypertension (DENERHTN) Trial.

  Azizi M, Pereira H, Hamdidouche I, Gosse P, Monge M, Bobrie G, Delsart P, Mounier-Véhier C, Courand PY, Lantelme P, Denolle T, Dourmap-Collas C, Girerd X, Michel Halimi J, Zannad F, Ormezzano O, Vaïsse B, Herpin D, Ribstein J, Chamontin B, Mourad JJ, Ferrari E, Plouin PF, Jullien V, Sapoval M, Chatellier G; DENERHTN Investigators. Azizi M, et al. Circulation. 2016 Sep 20;134(12):847-57. doi: 10.1161/CIRCULATIONAHA.116.022922. Epub 2016 Aug 30. Circulation. 2016. PMID: 27576780 Clinical Trial.
• Chemical renal denervation: an effective method to treat resistant hypertension?

  Toutouzas K, Synetos A, Pietri P, Stefanadis C. Toutouzas K, et al. EuroIntervention. 2017 Oct 13;13(9):e1129-e1130. doi: 10.4244/EIJ-D-16-01000L. EuroIntervention. 2017. PMID: 29033389 No abstract available.
• [Renal denervation: long-term Swiss experiences].

  Sudano I, Battegay E, Erne P, Lüscher TF. Sudano I, et al. Praxis (Bern 1994). 2015 Jan 2;104(1):27-31. doi: 10.1024/1661-8157/a001885. Praxis (Bern 1994). 2015. PMID: 25552444 Review. German.
• Is the failure of SYMPLICITY HTN-3 trial to meet its efficacy endpoint the "end of the road" for renal denervation?

  Epstein M, de Marchena E. Epstein M, et al. J Am Soc Hypertens. 2015 Feb;9(2):140-9. doi: 10.1016/j.jash.2014.12.002. Epub 2014 Dec 11. J Am Soc Hypertens. 2015. PMID: 25649995 Review.